CONNECT WITH US:
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 28, 2020 19:00 JST
Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
Apr 08, 2020 18:00 JST
Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
Mar 20, 2020 20:30 JST
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist for two of the prestigious Citeline Awards 2020 (formerly CARE Awards) by Informa Pharma Intelligence.
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
Mar 06, 2020 22:00 JST
Asia-Pacific's largest specialist biotech CRO Novotech has been selected for the Komipharm International clinical trials of Panaphix as a potential treatment for coronavirus - Covid-19.
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
Jan 21, 2020 10:40 JST
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment.
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
Jul 11, 2019 11:00 JST
Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31, 2019 07:00 JST
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs.
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
Apr 18, 2019 04:00 JST
Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has further strengthened its presence in South Korea with two major hospitals joining the Novotech partnership program - bringing more quality investigators, KOLs, and up to 4 million patients.
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
Mar 25, 2019 18:00 JST
Clinical Network Services (CNS) USA, an integrated service group focused on clinical product development, a subsidiary of Asia-Pacific specialist CRO Novotech, today announced the appointment of Dr Robert Malone as Principal Consultant in the Washington D.C. office.
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
Dec 17, 2018 08:00 JST
Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has implemented the Oracle's Trial Management and Monitoring Cloud Service (TMMCS) to support its growth in the Asia-Pacific.
Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
Nov 28, 2018 11:02 JST
Asia-Pacific specialist CRO Novotech announced today that clinical staff numbers in its Seoul, South Korea centre are now at 41, with 81 clinical research projects now completed.
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
Oct 19, 2018 07:00 JST
Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS), as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.
Novotech the Asia-Pacific CRO named Top 10 CRO
Aug 23, 2018 13:00 JST
Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook.
Sponsors Recommend Novotech for CRO Leadership Award
Aug 09, 2018 13:00 JST
Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" Award by Life Science Leader magazine based on findings from sponsor companies that utilise outsourcing services. In particular, Novotech was recognised for its local market/regulatory knowledge and for meeting timelines.
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials
Jul 19, 2018 06:00 JST
Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye Institute Inc (AEI), a private eye center in the Philippines, to facilitate high-quality and rapid feasibility, start-up and recruitment processes for its ophthalmology clients.
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
Jun 28, 2018 06:00 JST
Asia-Pacific CRO Novotech announced today at DIA Global Annual Meeting (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandum of Understandings (MOU) with five of the leading medical institutions in the region.
Novotech signs MoU with CMUH Taiwan to offer Enhanced Services for Global Trials
Jun 15, 2018 16:30 JST
Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MoU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/
Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials
Jun 12, 2018 11:00 JST
Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials
May 18, 2018 02:00 JST
Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds.
Novotech signs Central Lab Services Agreement with Sonic Clinical Trials
Jun 23, 2017 08:00 JST
Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare.
Novotech signs MOU with South Korea's leading medical center, the Asan Medical Center
Apr 18, 2017 10:00 JST
Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center. The MOU formalises Novotech's relationship with the internationally-leading medical center and its principal investigators.
New Research reveals Asia poised as Preferred Destination for Clinical Trials
Mar 09, 2017 11:00 JST
Frost & Sullivan released a white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific CRO Novotech presenting the findings to an audience of senior biotechnology and pharmaceutical executives in a private event at the Outsourcing in Clinical Trials - West Coast (OCT-WC 2017) conference, held Feb 22-23 in Burlingame, Ca. (USA).
New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials
Mar 03, 2017 14:00 JST
Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse.
Fujitsu Launches 14 New Models of Enterprise Notebooks, Tablets and Workstations Optimized for Remote Work
May 26, 2020 11:10 JST
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace
May 26, 2020 10:34 JST
Mitsubishi Motors Joins OPEN COVID-19 DECLARATION
May 26, 2020 09:34 JST
Tokyo Metropolitan Government to trial 5G Antenna-equipped Smart Poles in Cooperation with Sumitomo Corporation and NEC
May 25, 2020 10:44 JST
Mazda Begins Providing, Virtual Racing Car, Mazda RX-Vision GT3 Concept Online
May 22, 2020 14:26 JST
'e5 Consortium' Established to Promote Zero-Emission Electric Vessel
May 21, 2020 15:34 JST
TOYOTA GAZOO Racing Decides Not to Participate in 2020 Edition of Nurburgring 24 Hours
May 21, 2020 14:19 JST
Fujitsu RunMyProcess Drives Next Phase of Digital Transformation in Business Processes with DigitalSuite ProcessModeler
May 21, 2020 09:00 JST
MHPS Captures Global Gas Turbine Market Share Leadership Again
May 20, 2020 10:09 JST
Hitachi Awarded Contract to Supply, Install 300 Lifts at HDB Blocks in Singapore
May 19, 2020 11:57 JST
DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia
May 18, 2020 17:36 JST
Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules
May 18, 2020 13:33 JST
Hitachi to Provide $1 Million in Loans through Kiva to Businesses in Need around the Globe, Affected by the Spread of the COVID-19
May 18, 2020 13:24 JST
Toyota's Adjustments to Domestic Production in June 2020 (as of May 15)
May 15, 2020 17:01 JST
Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050
May 15, 2020 14:10 JST
Fujitsu and Accenture Collaboration Accelerates Reliable Blockchain Interoperability
May 15, 2020 10:11 JST
Mazda Releases FY March 2020 Full Year Financial Results
May 14, 2020 17:01 JST
Fujitsu Sets Out the 'Fujitsu Technology and Service Vision 2020'
May 14, 2020 15:53 JST
Notice of Agreement for the Merger through Absorption (Simplified Absorption-type Merger) of a Consolidated Subsidiary of Fujitsu Limited
May 14, 2020 15:46 JST
Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting
May 14, 2020 09:22 JST
More Latest Release >>